Molecular basis of extended-spectrum β-lactamase production in nosocomial isolates of Klebsiella pneumoniae from Merida, Venezuela

International Journal of Antimicrobial Agents

Volumn 15, Issue 1, 2000, Pages 37-42

  Araque, María ^a,b   Nieves, Beatriz ^a   Lauretti, Laura ^b   Rossolini, Gian Maria ^b  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Extended spectrum lactamases; Klebsiella pneumoniae; Nosocomial infections; SHV 5 lactamase; TEM 1 lactamase; Transferable resistance determinants

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; GENTAMICIN; IMIPENEM; KANAMYCIN; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CONJUGATION; DNA SEQUENCE; HOSPITAL INFECTION; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS; VENEZUELA;

EID: 0034128223     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00168-5     Document Type: Article

References (25)

1. Thomson K.S., Prevan A.M., Sanders C.C. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics. Remington J.S., Swartz M.N. Current Clinical Topics in Infectious Diseases. 16th ed. 1996;151-163 Blackwell Science, Inc, Cambridge, MA.
2. Livermore D.M. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:1995;557-584.
3. Medeiros A.A. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24(Suppl 1):1997;19-45.
4. Livermore D.M. Lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41(Suppl. D):1998;25-41.
5. Kliebe C., Berthold A.N., Meyer J.F., Tolxdorff-Neutzling R.M., Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28:1985;302-307.
6. Sirot J., Chanal C., Petit A., Sirot D., Labia R., Gerbaud G. Klebsiella pneumoniae and other enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third generation cephalosporins: epidemiologic studies. Rev. Infect. Dis. 10:1988;850-859.
7. Araque M., Velazco E. In Vitro activity of fleroxacin against multiresistant gram-negative bacilli isolated from patients with nosocomial infections. Intens. Care Med. 24:1998;839-844.
8. Pfaller M.A., Jones R.N., Doern G.V. Multicenter evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Venezuela using the Etest method. Diagn. Microbiol. Infect. Dis. 30:1998;45-52.
9. Kholodii G.Ya, Mindlin S.Z., Bass I.A., Yurieva O.V., Minakhina S.V., Nikiforov V.G. Four genes, two ends, and a res region are involved in transposition of Tn5053: a paradigm for a novel family of transposons carrying either a mer operon or an integron. Mol. Microbiol. 17:1995;1198-1200.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard. NCCLS Document M7-A4. Villanova, PA, National Committee for Clinical Laboratory Standards, 1997.
11. Jarlier V., Nicolas M., Fournier G., Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:1988;867-878.
12. Willets N. Conjugation. Methods Microbiol. 17:1984;33-59.
13. Miller J. Experiments in Molecular Genetics. 1972;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: a Laboratory Manual. 2nd ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Kado C.I., Liu S.T. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1981;1365-1373.
16. Sutcliffe J.G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA. 75:1978;3737-3741.
17. Barthélémy M., Péduzzi J., Labia R. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-1). Biochem. J. 251:1988;73-79.
18. Billot-Klein D., Gutmann L., Collatz E. Nucleotide sequence of the SHV-5 β-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:1990;2439-2441.
19. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:1998;589-603.
20. Gutmann L., Ferré B., Goldstein W. et al. SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob. Agents Chemother. 33:1989;951-956.
21. Shaw K.J., Rather P.N., Hare R.S., Miller G.H. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:1993;138-163.
22. Mabilat C., Courvalin P. Development of 'oligotyping' for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 34:1990;2210-2216.
23. Sirot D., De Champs C., Chanal C. et al. Translocation of antibiotic resistance determinants including and extended-spectrum β-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 35:1991;1576-1581.
24. Heritage J., Hawkey P.M., Todd N., Lewis I.J. Transposition of the gene encoding a TEM-12 extended-spectrum β-lactamase. Antimicrob. Agents Chemother. 36:1992;1981-1986.
25. Araque M., Nieves B., Ruíz O., Dagert M. Caracterización de plásmidos que median la resistencia a múltiples antibióticos en bacterias gramnegativas de origen nosocomial. Enferm. Infecc. Microbiol. Clin. 15:1997;299-305.